Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Aurobindo Pharma Gets FDA Approval for Naproxen Painkiller Pill

Nov. 2 (Bloomberg) -- Aurobindo Pharma Ltd., an Indian supplier to Pfizer Inc., received approval from the U.S. Food and Drug Administration for its naproxen sodium painkiller, the generic version of Bayer AG’s Aleve, according to a statement on the regulator’s website.

Link to Company News:{3400398Z US <Equity> CN <GO>} Link to Company News:{ARBP IN <Equity> CN <GO>} Link to Company News:{BAYN GR <Equity> CN <GO>}

To contact the reporter on this story: Adi Narayan in Mumbai at anarayan8@bloomberg.net

To contact the editor responsible for this story: Niveditha Ravi at nravi2@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.